Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Understanding atopic dermatitis in Israel

Four modifiable risk factors contribute 63% of the annual costs of CVD across Asia-Pacific, according to new study by The Economist Intelligence Unit

Protecting the heart: Preventing cardiovascular disease in Asia

The Cost of Silence: Cardiovascular disease in Asia

The Cost of Silence: Cardiovascular disease in Asia is a report by The Economist Intelligence Unit and EIU Healthcare. It provides a study of the economic impact of CVD risk factors on the following Asian markets: China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.

The Cost of Silence

Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient.

Understanding atopic dermatitis in Italy

Understanding atopic dermatitis in Australia

Priorities of progress: understanding citizens' voices

Commissioned by Nitto Denko, The Economist Intelligence Unit produced a global study Priorities of progress: understanding citizens’ voices, that sheds light on citizens’ priorities among issues that range from healthcare, education, social protection, public safety, R&D, to the environment and transport infrastructure. The report builds insights from a 50-country citizen survey and interviews with a panel of experts and measures survey responses against publicly available spending data of governments.

A misunderstood skin disease: Mapping the policy response to atopic dermatitis

A misunderstood skin disease: Mapping the policy response to atopic dermatitis

Atopic dermatitis (AD), also known as eczema or atopic eczema (AE), is a common chronic inflammatory non-communicable skin disease that often manifests itself in flares of dry, red and itchy skin. It is not a well-understood disease. Lifetime prevalence can vary widely across the globe, ranging from 9% to 32%. 

For those without direct experience, it can be challenging to understand the lengths to which cracked, itchy skin can overwhelm a person’s quality of life, as well as affect the lives of their family and caregivers.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week